Skip to main content
Screener/Healthcare/Biotechnology

SPRY ARS Pharmaceuticals, Inc.

NASDAQ
$9.80-0.04 (-0.41%)
$6.66
$18.90
$9.57
$9.91
EPS (TTM)$-2.01
P/E Ratio-4.57
Dividend Yield
Market Cap$969.2M
Volume637K
Prev Close$9.81
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$22.7M-$60.6M$-0.6172.3%-267.3%
Q4 '25$28.1M-$41.3M$-0.4288.6%-147.1%
Q3 '25$32.5M-$51.2M$-0.5274.8%-157.4%
Q2 '25$15.7M-$44.9M$-0.4668.3%-285.6%
Q1 '25$8.0M-$33.9M$-0.3549.3%-425.7%
Q4 '24$86.6M$49.9M$0.5195.5%57.7%
Q3 '24$2.1M-$19.1M$-0.2094.6%-925.0%
Q2 '24$500K-$12.5M$-0.13100.0%-2503.2%
Get Your Daily Market Recap